Schröder K, Zeymer U, Wegschneider W, Schröder R
Frankenklinik, Bad Neustadt/Saale, Germany.
Z Kardiol. 2004 Aug;93(8):595-604. doi: 10.1007/s00392-004-0102-4.
Simple and rapid measures are needed for timely assessment of the quality of reperfusion therapy early after fibrinolysis in acute STEMI. Sum ST segment elevation resolution (sum STR) categorized into the three groups of low risk (complete ST resolution), medium risk (partial ST resolution), and high risk (no ST resolution) has become an established method to predict infarct size, left ventricular function, epicardial vessel patency, and mortality. However, measurement of the sum of ST elevation from all leads of repeated ECG's is time-consuming. For routine practice more simple measures are needed. This report summarizes recent findings on direct comparisons between different modes of evaluation of ST segment deviation recovery employed for risk stratification in large-scale mortality trials. With respect to predictive accuracy combined with simplicity, two methods were superior to the conventional model of sum STR: 1) ST segment deviation resolution in only the one ECG lead showing the maximal deviation (single lead STR), and 2) the existing ST segment deviation in the single ECG lead of maximum deviation present 90 or 180 min after start of fibrinolysis (max STE). In multivariate analyses the ST segment deviation recovery models including sum STR were significant independent predictors of short- and long-term mortality. In receiver-operating characteristic (ROC) curves for predicting mortality the analysis of single lead STR and max STE performed better than sum STR. After categorization into risk groups patients are best classified by max STE. With an ECG recorded at 90 min in 2719 patients, the proportion of patients of sum STR, single lead STR, and max STE were 40, 34, and 43% in the low risk groups, and 24, 31, and 25% in the high risk groups. Cardiac mortality rates at 30 days were 2.0, 1.2, and 1.0% in low risk versus 9.6, 10.3, and 12.8% in the high risk groups, respectively. Long-term mortality with a followup of 5 years was best predicted by max STE risk groups.
Single lead STR and max STE are very simple, inexpensive, non-invasive, and highly reliable measures which provide very strong early prognostic information. The relationship between degree of ST segment deviation recovery and subsequent mortality is remarkably consistent. Both methods perform better than sum STR in predicting mortality. They can be used for very early risk stratification and can form a basis for an individual treatment of patients after fibrinolysis for STEMI within 6 hours of symptom onset. Of the two methods max STE is even simpler to use and has better accuracy in predicting outcome.
急性ST段抬高型心肌梗死(STEMI)溶栓治疗后,需要简单快速的方法来及时评估再灌注治疗的质量。将ST段抬高总和分辨率(sum STR)分为低风险(ST段完全恢复)、中风险(ST段部分恢复)和高风险(ST段未恢复)三组,已成为预测梗死面积、左心室功能、心外膜血管通畅情况及死亡率的既定方法。然而,测量多次心电图所有导联的ST段抬高总和很耗时。在常规实践中,需要更简单的方法。本报告总结了大规模死亡率试验中用于风险分层的ST段偏移恢复不同评估模式直接比较的最新研究结果。就预测准确性和简单性而言,有两种方法优于传统的sum STR模型:1)仅在显示最大偏移的一个心电图导联中的ST段偏移分辨率(单导联STR),以及2)溶栓开始后90或180分钟时最大偏移的单个心电图导联中的现有ST段偏移(最大ST抬高,max STE)。在多变量分析中,包括sum STR的ST段偏移恢复模型是短期和长期死亡率的重要独立预测因素。在预测死亡率的受试者工作特征(ROC)曲线中,单导联STR和max STE的分析表现优于sum STR。在分为风险组后,患者最好根据max STE进行分类。在2719例患者中于90分钟记录心电图,低风险组中sum STR、单导联STR和max STE的患者比例分别为40%、34%和43%,高风险组中分别为24%、31%和25%。低风险组30天心脏死亡率为2.0%、1.2%和1.0%,高风险组分别为9.6%、10.3%和12.8%。随访5年的长期死亡率最好由max STE风险组预测。
单导联STR和max STE是非常简单、廉价、无创且高度可靠的方法,可提供非常有力的早期预后信息。ST段偏移恢复程度与随后死亡率之间的关系非常一致。两种方法在预测死亡率方面均优于sum STR。它们可用于极早期风险分层,并可为症状发作6小时内STEMI溶栓治疗后的患者个体化治疗提供依据。两种方法中,max STE使用更简单,预测结局的准确性更高。